Emerging AI-Driven Biotech Sybleu, Inc. (OTC:SYBE) offers competitive advantages and upcoming milestones in the stock market's top-followed and funded segment, AI, prompting a potential surge in the stock price.
|
Read more...
|
Interactive Strength, Inc. (NASDAQ: TRNR) d/b/a FORME is about to make a profound change in its business that will prompt major growth, accelerate profit, and drive the artificially low valuation substantially higher.
|
Read more...
|
Leveraging a $150M M&A-targeted credit facility, and a core relationship with Deepak Chopra, integrated health firm The Healing Company, Inc. (OTCQB: HLCO) is poised to record exponential revenue growth.
|
Read more...
|
Fresh off a successful IPO, NeurAxis Inc. (NYSE Amer: NRXS) is in the role of first mover with an FDA-cleared product in a huge market opportunity.
|
Read more...
|
New is a good thing. Sadot Group, Inc. (NASDAQ: SDOT) is the new name and symbol for Muscle Maker, Inc. (NASDAQ: GRIL) and its new initiatives will drive revenue and income growth.
|
Read more...
|
AccuStem Sciences, Inc. (OTCQB: ACUT) is revolutionizing cancer diagnostics and appears to be a strong acquisition candidate.
|
Read more...
|
OKYO Pharma Limited (NASDAQ: OKYO) just commenced a Phase II clinical trial and with top-line data to be published by year-end, this catalyst could prompt a major re-valuation of the stock.
|
Read more...
|
Muscle Maker, Inc. (NASDAQ: GRIL) is set to grow revenue from $162M in 2022 to over $1B in 2024, with a substantial rise in adjusted net income, thereby driving its share price to new highs
|
Read more...
|
In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.
|
Read more...
|
Charlie's Holdings, Inc. (OTCQB: CHUC), a leader in its underlying space appear set to hit new highs as it generates huge sales growth, leverages industry trends, trades at a discount to its peer group, will be up-listing to a national exchange, and benefits from investors finally focusing on current trends and successes instead of only a potential home run scenario.
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
Page 1 of 47 |